These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20429391)

  • 21. New England Compounding Center Indictment.
    Cabaleiro J
    Int J Pharm Compd; 2015; 19(2):94-102. PubMed ID: 26685489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When pharmacies cause harm.
    Jha VM
    Chest; 2013 Aug; 144(2):717. PubMed ID: 23918132
    [No Abstract]   [Full Text] [Related]  

  • 23. [Interview -- drug legislation -- reporting unexpected adverse drug reactions].
    Ludwig WD
    Pneumologie; 2009 Sep; 63(9):479-80. PubMed ID: 19764017
    [No Abstract]   [Full Text] [Related]  

  • 24. Panel discussion: in process control and inspection for quality assurance. 3.
    Brofazi FR
    Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572
    [No Abstract]   [Full Text] [Related]  

  • 25. [Standards imposed by the pharmacopoeia on drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534
    [No Abstract]   [Full Text] [Related]  

  • 26. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on legal issues associated with tardive dyskinesia.
    Slovenko R
    J Clin Psychiatry; 2000; 61 Suppl 4():45-57. PubMed ID: 10739331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Home Field Disadvantage.
    Cabaleiro J
    Int J Pharm Compd; 2016; 20(1):86-7. PubMed ID: 27125059
    [No Abstract]   [Full Text] [Related]  

  • 29. [Quality control in the pharmaceutical industry].
    Sloot HA
    Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061
    [No Abstract]   [Full Text] [Related]  

  • 30. When does compounding become manufacturing?
    Gushee J
    J Am Vet Med Assoc; 1994 Jul; 205(2):235-6. PubMed ID: 7928585
    [No Abstract]   [Full Text] [Related]  

  • 31. Contemporary pharmaceutical compounding.
    Allen LV
    Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042
    [No Abstract]   [Full Text] [Related]  

  • 32. Off-label promotion.
    Somberg J
    Am J Ther; 2006; 13(5):387. PubMed ID: 16988530
    [No Abstract]   [Full Text] [Related]  

  • 33. [Technicoscientific evolution and current direction of the standards regulating drug registration in Italy and in the European Economic Community].
    Battaglino G
    Boll Chim Farm; 1978 Jun; 117(6):313-24. PubMed ID: 743380
    [No Abstract]   [Full Text] [Related]  

  • 34. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 35. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
    Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
    [No Abstract]   [Full Text] [Related]  

  • 36. Botanical drugs: a future for herbal medicines.
    Li W
    J Contemp Health Law Policy; 2002; 19(1):117-49. PubMed ID: 12733224
    [No Abstract]   [Full Text] [Related]  

  • 37. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry.
    Wallhäusser KH
    J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623
    [No Abstract]   [Full Text] [Related]  

  • 38. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 40. Current good manufacturing practice regulations.
    Bumiller J
    Bull Parenter Drug Assoc; 1971; 25(5):222-5. PubMed ID: 5094094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.